## Abstract The synthesis of new bioisosteric analogues of farnesyl pyrophosphate where a vinyl pyrophosphonate replaced the pyrophosphate moiety is described. These compounds have been prepared using a HornerโWadsworthโEmmons procedure and a modified Michelson reaction. They have been evaluated fo
Inhibitors of Protein:Farnesyl Transferase and Protein:Geranylgeranyl Transferase I: Synthesis of Homologous Diphosphonate Analogs of Isoprenylated Pyrophosphate
โ Scribed by Mark Overhand; Hanneke R. Stuivenberg; Elsbet Pieterman; Louis H. Cohen; Rick E.W. van Leeuwen; A.Rob P.M. Valentijn; Herman S. Overkleeft; Gijs A. van der Marel; Jacques H. van Boom
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 297 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0045-2068
No coin nor oath required. For personal study only.
โฆ Synopsis
Novel diphosphonate homologs 7a-7c, and their cyclic counterparts 8a-8c, of the previously synthesized farnesyl pyrophosphate analogs 1 and 2 were prepared and tested for their inhibition potency and specificity of the enzymes PFT and PGGT-I. Compound 2 was shown to be the most potent inhibitor of PFT (IC 50 ฯญ 0.58 ฯฎ 0.45 ศM) in this series. The novel compound 7a, the one carbon homolog of 2, proved to be the most potent inhibitor of PGGT-I (IC 50 ฯญ 0.98 ฯฎ 0.01 ศM). The cyclic analogs 8a-8c are generally less biologically active. The compounds 2 and 7a are nonspecific toward inhibition of PFT and PGGT-I and may inhibit both farnesylation and geranylgeranylation processing of oncogenic proteins.
๐ SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a โFull Textโ option. The original article is trackable v
Novel Tricyclic Aminoacetyl and Sulfonamide Inhibitors of RAS Farnesyl Protein Transferase. -It is shown that derivatization of the amino group with a phthaloyl moiety increases inhibitory activity of the title compounds, cf. (IIIc) and (IIId). The potent inhibitors (III) and (V) are non-peptidic,